Skip Navigation LinksHome > October 2013 - Volume 33 - Issue 5 > α1-Adrenergic Receptors Contribute to the Acute Effects of 3...
Journal of Clinical Psychopharmacology:
doi: 10.1097/JCP.0b013e3182979d32
Original Contributions

α1-Adrenergic Receptors Contribute to the Acute Effects of 3,4-Methylenedioxymethamphetamine in Humans

Hysek, Cédric M. PhD*; Fink, Anja E. MD*; Simmler, Linda D. PhD*; Donzelli, Massimiliano MSc*; Grouzmann, Eric PhD; Liechti, Matthias E. MD, MAS*

Supplemental Author Material
Collapse Box


Abstract: Preclinical studies implicate a role for α1-noradrenergic receptors in the effects of psychostimulants, including 3,4-methylenedioxymethamphetamine (MDMA, “ecstasy”). The present study evaluated the effects of the α1-noradrenergic receptor antagonist doxazosin on the acute pharmacodynamic and pharmacokinetic response to MDMA in 16 healthy subjects. Doxazosin (8 mg/d) or placebo was administered for 3 days before MDMA (125 mg) or placebo using a randomized, double-blind, placebo-controlled, 4-session, crossover design. Doxazosin reduced MDMA-induced elevations in blood pressure, body temperature, and moderately attenuated positive mood but enhanced tachycardia associated with MDMA. The results indicate that α1-adrenergic receptors contribute to the acute cardiostimulant and to a minor extent possibly also to the thermogenic and euphoric effects of MDMA in humans.

© 2013 by Lippincott Williams & Wilkins.


Article Tools


Article Level Metrics

Search for Similar Articles
You may search for similar articles that contain these same keywords or you may modify the keyword list to augment your search.